Literature DB >> 8258190

Effect of cyclosporine on colchicine partitioning in the rat liver.

K V Speeg1, A L Maldonado.   

Abstract

Colchicine is secreted into bile as a major pathway of elimination. Cyclosporine (CsA) inhibits colchicine biliary secretion. In the present study, the effects of cyclosporine and its vehicle (cremophor) on the partitioning of colchicine across the liver were studied. CsA decreased the colchicine bile/plasma ratio from 484 +/- 39 to 53 +/- 3 (P < 0.001). This effect was due to both a decrease in bile/liver partitioning (control, 35.1 +/- 1.2, vs CsA treatment, 9.2 +/- 0.5; p < 0.001) as well as a decrease in liver/plasma partitioning (control, 13.7 +/- 0.8, vs CsA treatment, 5.7 +/- 0.4; P < 0.001). Cremophor also decreased the colchicine bile/plasma ratio (317 +/- 19, P < 0.02 vs control), but this effect was due to a decrease in the liver/plasma ratio (9.99 +/- 0.7, P < 0.02 vs control) rather than the bile/liver ratio (31.9 +/- 2.1, P > 0.2 vs control). Inhibition at the canalicular membrane is consistent with the location of gp-170, the presumed transporter of colchicine.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8258190     DOI: 10.1007/bf00685886

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  18 in total

1.  Identification of the multidrug resistance-related P-glycoprotein as a cyclosporine binding protein.

Authors:  B M Foxwell; A Mackie; V Ling; B Ryffel
Journal:  Mol Pharmacol       Date:  1989-10       Impact factor: 4.436

2.  Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein.

Authors:  F Thiebaut; T Tsuruo; H Hamada; M M Gottesman; I Pastan; M C Willingham
Journal:  J Histochem Cytochem       Date:  1989-02       Impact factor: 2.479

3.  Cyclosporine-induced cholestasis: inhibition of bile acid secretion is caused by the parental molecule.

Authors:  B Le Thai; M Dumont; A Michel; S Erlinger; D Houssin
Journal:  Transplant Proc       Date:  1987-10       Impact factor: 1.066

4.  Tissue distribution of P-glycoprotein encoded by a multidrug-resistant gene as revealed by a monoclonal antibody, MRK 16.

Authors:  I Sugawara; I Kataoka; Y Morishita; H Hamada; T Tsuruo; S Itoyama; S Mori
Journal:  Cancer Res       Date:  1988-04-01       Impact factor: 12.701

5.  Effect of cyclosporine on colchicine secretion by a liver canalicular transporter studied in vivo.

Authors:  K V Speeg; A L Maldonado; J Liaci; D Muirhead
Journal:  Hepatology       Date:  1992-05       Impact factor: 17.425

6.  ATP-dependent primary active transport of cysteinyl leukotrienes across liver canalicular membrane. Role of the ATP-dependent transport system for glutathione S-conjugates.

Authors:  T Ishikawa; M Müller; C Klünemann; T Schaub; D Keppler
Journal:  J Biol Chem       Date:  1990-11-05       Impact factor: 5.157

7.  Effect of chronic administration of cyclosporin A on hepatic uptake and biliary secretion of bromosulfophthalein in rat.

Authors:  J F Cadranel; M Dumont; V A Mesa; C Degott; D Touchard; S Erlinger
Journal:  Dig Dis Sci       Date:  1991-02       Impact factor: 3.199

8.  Reduced cyclosporin accumulation in multidrug-resistant cells.

Authors:  H Goldberg; V Ling; P Y Wong; K Skorecki
Journal:  Biochem Biophys Res Commun       Date:  1988-04-29       Impact factor: 3.575

9.  Cyclosporin A reverses vincristine and daunorubicin resistance in acute lymphatic leukemia in vitro.

Authors:  L M Slater; P Sweet; M Stupecky; S Gupta
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

10.  Modification of cytotoxic drug resistance by non-immuno-suppressive cyclosporins.

Authors:  P R Twentyman
Journal:  Br J Cancer       Date:  1988-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.